Compare BBGI & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBGI | PAVM |
|---|---|---|
| Founded | 1961 | 2014 |
| Country | United States | United States |
| Employees | N/A | 107 |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 8.7M |
| IPO Year | 1999 | N/A |
| Metric | BBGI | PAVM |
|---|---|---|
| Price | $4.33 | $10.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | 24.1K | ★ 127.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $232,179,463.00 | N/A |
| Revenue This Year | $5.02 | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 69.89 | N/A |
| 52 Week Low | $3.71 | $0.21 |
| 52 Week High | $26.37 | $28.44 |
| Indicator | BBGI | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 57.13 |
| Support Level | $3.78 | $0.39 |
| Resistance Level | $4.52 | $12.50 |
| Average True Range (ATR) | 0.24 | 0.96 |
| MACD | 0.03 | -0.22 |
| Stochastic Oscillator | 50.18 | 55.67 |
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.